Galapagos CEO increases shareholding
(Thomson Reuters ONE) - Mechelen, Belgium; 7 December 2009 - Galapagos NV (Euronext: GLPG)announced today a capital increase of ?902,564 and the issue of225,641 new shares as a result of the exercise of warrants byGalapagos warrant holders, including CEO Onno van de Stolpe. Mr. vande Stolpe obtained 210,766 new shares as a result of the exercise ofwarrants and now holds 290,976 shares in Galapagos, representing1.23% of total outstanding shares.Since its inception in 1999, Galapagos has used warrant plans as anincentive and to allow personnel and management to be involved in theCompany's growth and development. The warrants exercised weregranted in March 2002 and April 2003 under the Warrant Plan Belgium2002 with a warrant exercise price of ?4.00 to obtain one share and alife time of 8 years. The warrants granted in March 2002 will expirein March 2010 and the last window during which they could beexercised was the window that ended on 30 November 2009. InSeptember 2009 Mr. van de Stolpe committed to making use of this lastpossible window to exercise all warrants granted to him in March2002. Mr. van de Stolpe still holds all Galapagos shares that he hasacquired through the market and warrant exercises.With this capital increase, Galapagos now has 23,610,820 sharesoutstanding and a share capital of ?127,723,203.20.About GalapagosGalapagos (Euronext: GLPG; OTC: GLPYY) is a drug discovery anddevelopment company with small molecule programs in bone and jointdiseases, bone metastasis, cachexia, anti-infectives and metabolicdiseases. It has established risk sharing alliances with GSK,Janssen Pharmaceutica, Eli Lilly and Merck and Co. Through analliance with MorphoSys, Galapagos is also developing new antibodytherapies in bone and joint diseases. Its division BioFocus offers afull suite of target-to-drug discovery products and services topharmaceutical and biotech companies and to patient foundations,encompassing target discovery and validation, screening and drugdiscovery through to delivery of pre-clinical candidates. Galapagoscurrently employs 495 people and operates facilities in sixcountries, with global headquarters in Mechelen, Belgium. More infoat: www.glpg.com.CONTACTGalapagos NVElizabeth Goodwin, Director Investor RelationsTel: +31 62 291 6240ir(at)glpg.comThis release may contain forward-looking statements, including,without limitation, statements containing the words "believes,""anticipates," "expects," "intends," "plans," "seeks," "estimates,""may," "will," "could," "stands to," and "continues," as well assimilar expressions. Such forward-looking statements may involveknown and unknown risks, uncertainties and other factors which mightcause the actual results, financial condition, performance orachievements of Galapagos, or industry results, to be materiallydifferent from any historic or future results, financial conditions,performance or achievements expressed or implied by suchforward-looking statements. Given these uncertainties, the reader isadvised not to place any undue reliance on such forward-lookingstatements. These forward-looking statements speak only as of thedate of publication of this document. Galapagos expressly disclaimsany obligation to update any such forward-looking statements in thisdocument to reflect any change in its expectations with regardthereto or any change in events, conditions or circumstances on whichany such statement is based, unless required by law or regulation.This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 07.12.2009 - 07:30 Uhr
Sprache: Deutsch
News-ID 9324
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 656 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Galapagos CEO increases shareholding"
steht unter der journalistisch-redaktionellen Verantwortung von
Galapagos NV (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
